Acurx Pharmaceuticals, Inc.

  • Home
  • About
    • Management / Consultants
    • Scientific / Corporate Advisors
    • Board of Directors
  • Pipeline
    • Overview
    • Ibezapolstat
    • GPSS®
    • Publications
  • News & Media
    • Press Releases
    • Presentations
    • Videos
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

ALERT: NEW ARTICLE

New England Journal of Medicine , “One Pivotal Trial, the New Default Option for FDA Approval – Ending the Two-Trial Dogma,” by Vinay Prasad, M.D., M.P.H.1 and Martin A. Makary, M.D., M.P.H.1

Read Publication

Continue

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Videos

Acurx Pharmaceuticals, Inc. to Discuss 2022 Third Quarter Financial Results on November 14, 2022 Conference Call and Provide Business Update

Nov 1, 2022

Acurx Announces Scientific Oral and Poster Presented at IDWeek 2022

Oct 26, 2022

Acurx Announces Scientific Oral and Poster Presentations at IDWeek

Oct 17, 2022

Acurx Pharmaceuticals, Inc. Reports Second Quarter 2022 Results and Provides Business Update

Aug 15, 2022

Acurx Pharmaceuticals, Inc. to Discuss 2022 Second Quarter Financial Results on August 16, 2022 Conference Call and Provide Business Update

Aug 4, 2022

Acurx Announces New Data Presentations from Ongoing Ph2 Clinical Trial Program of Ibezapolstat for CDI at the 16th Biennial Congress of the Anaerobe Society of America

Aug 2, 2022

Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering

Jul 25, 2022

Acurx Pharmaceuticals, Inc. Reports First Quarter 2022 Results and Provides Business Update

May 11, 2022

Acurx Pharmaceuticals, Inc. to Discuss 2022 First Quarter Financial Results on May 11, 2022 Conference Call and Provide Business Update

Apr 29, 2022

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update

Mar 17, 2022
    • 1...
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    © 2026 Acurx Pharmaceuticals, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap